Lombardi Comprehensive Cancer Center — Washington D.C., District of Columbia

Lombardi Comprehensive Cancer Center is a clinical research site located in Washington D.C., District of Columbia, United States 22057.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Lombardi Comprehensive Cancer Center has participated in 18 clinical trials with 6 currently active.

Therapeutic areas: Advanced Solid Tumors, Warm Antibody Autoimmune Hemolytic Anemia, Acral Lentiginous Melanoma.

Sponsors: Bristol-Myers Squibb, Rigel Pharmaceuticals, Georgetown University.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lombardi Comprehensive Cancer Center?

Lombardi Comprehensive Cancer Center has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lombardi Comprehensive Cancer Center conducted?

Lombardi Comprehensive Cancer Center has 18 clinical trials on record, with 6 currently active. Their work covers Advanced Solid Tumors, Warm Antibody Autoimmune Hemolytic Anemia, Acral Lentiginous Melanoma.

Is Lombardi Comprehensive Cancer Center accredited by Crixeo Health?

Yes — Lombardi Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Lombardi Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.